Home/Nascent Biotech/Lowell Holden
LH

Lowell Holden

Chief Financial Officer & Director

Nascent Biotech

Therapeutic Areas

Nascent Biotech Pipeline

DrugIndicationPhase
Pritumumab (PTB)Gliomas (Brain Tumors)Phase II
Pritumumab-based ADCUndisclosed CancersDiscovery